Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-003002

Director sold 6,450 shares at $8.75 ($56,454)

From the SEC's structured data for this filing

Trades in this filing

Sinha Vikas · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-20 Sale : show line 1 in the form −6,450 $8.75 $56,454 858,957 D
Open-market sales · 6,450 sh · avg $8.75 · $56,454
Loading xslF345X03/doc4.xml…